First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis	Active, not recruiting	Phase 1	2026-03-10		NCT06050356

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aurum Institute	4
Bill and Melinda Gates Foundation	67
Leiden University Medical Center	183
South African Tuberculosis Vaccine Initiative	1
Statens Serum Institut	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aurum Institute	Pretoria	South Africa	1